Publications

4917 Results

Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin

Authors
A List;Z Sun;A Verma;J Bennett;R Komrokji;K McGraw;L Nardelli;J Maciejewski;J Altman;P Cheema;D Claxton;S Luger;R Mattison;T Wassenaar;A Artz;C Schiffer;M Litzow;M Tallman
Journal / Conference
Journal of Clinical Oncology Jan 13;JCO2001691. doi: 10.1200/JCO.20.01691. Online ahead of print.
Year
2021
Research Committee(s)
Leukemia
PMID
PMID33439748
Study Number(s)
CTSU/E2905

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

Authors
G Nowakowski;F Hong;D Scott;W Macon;R King;T Habermann;M Wagner-Johnston;C Casulo;JL Wade, III;G Nagargoje;C Reynolds;J Cohen;N Khan;J Amengual;K Richards;R Little;J Leonard;JW Friedberg;L Kostakoglu;B Kahl;T Witzig
Journal / Conference
Journal of Clinical Oncology Feb 8;JCO2001375. doi: 10.1200/JCO.20.01375. Online ahead of print
Year
2021
Research Committee(s)
Lymphoma
PMID
PMID33555941
Study Number(s)
CTSU/E1412

Midostaurin reduces the cumulative incidence of relapse and is tolerable for maintenance in FLT3-mutant acute myeloid leukemia (CALGB 10603)

Authors
RA Larson;S Mandrekar;L Huebner;B Sanford;C Laumann;S Geyer;C Bloomfield;C Thiede;T Prior;K Dohner;G Marcucci;M Voso;R Klisovic;I Galinsky;A Wei;J Sierra;M Sanz;J Brandwein;T de Witte;D Niederwieser;F Appelbaum;B Medeiros;M Tallman;J Krauter;R Schlenk;R Ganser;H Serve;G Ehninger;S Amadori;I Gathmann;H Dohner;R Stone
Journal / Conference
Blood Mar 2. doi: 10.1038/s41375-021-01179-4. Online ahead of print, 2021
Year
2021
Research Committee(s)
Leukemia
PMID
PMID33654204
Study Number(s)
CTSU/C10603

Patient Reported Outcomes and Long-Term Non-Adherence to Aromatase Inhibitors

Authors
D Hershman;A Neugut;A Moseley;K Arnold;J Gralow;NL Henry;G Clarke Hillyer;S Ramsey;J Unger
Journal / Conference
Journal of the National Cancer Institute Feb 25:djab022, 2021. doi: 10.1093/jnci/djab022. Online ahead of print.
Year
2021
Research Committee(s)
Cancer Care Delivery
PMID
PMID33629114
Study Number(s)
S1105

Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study

Authors
N Dimou;N Papadimitriou;D Mariosa;M Johansson;P Brennan;U Peters;S Chanock;M Purdue;D Bishop;M Gago-Dominguez;G Giles;V Moreno;E Platz;C Tangen;A Wolk;W Zheng;X Wu;P Campbell;E Giovannucci;Y Lin;M Gunter;N Murphy
Journal / Conference
International Journal of Cancer Apr 1;148(7):1625-1636
Year
2021
Research Committee(s)
Prevention
PMID
PMID33038280
PMC
PMC7894468
Study Number(s)
S0000

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer

Authors
R Karunamuni;M Huynh-le;C Fan;W Thompson;R Eeles;Z Kote-Jarai;C Tangen;D Albanes;M Roobol;W Zheng;I Mills;O Andreassen;A Dale;T Seibert
Journal / Conference
Prostate Cancer and Prostatic Diseases Jan 8. doi: 10.1038/s41391-020-00311-2. Online ahead of print
Year
2021
Research Committee(s)
Cancer Control and Prevention
PMID
PMID33420416
Study Number(s)
S0000, SWOG-9217

Smoking modifies pancreatic cancer risk loci on 2q21.3

Authors
E Mocci;P Kundu;W Wheeler;A Arslan;L Freeman;P Bracci;P Goodman;D Albanes;C Fuchs;JM Gaziano;IM Thompson;B Wolpin;H Risch;P Kraft;N Chatterjee;A Klein;R Stolzenberg-Solomon
Journal / Conference
Cancer Research Feb 11;canres.3267.2020. doi: 10.1158/0008-5472.CAN-20-3267. Online ahead of print
Year
2021
Research Committee(s)
Prevention
PMID
PMID33574088
Study Number(s)
S0000

A Latent Disease Model to Reduce Detection Bias in Cancer Risk Prediction Studies

Authors
S Aleshin-Guendel;J Lange;P Goodman;N Weiss
Journal / Conference
Evaluation and the Health Professions Mar;44(1):42-49
Year
2021
Research Committee(s)
Prevention
PMID
PMID33506704
Study Number(s)
S0000

Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (LungMAP SWOG S1400GEN)

Authors
J Roth;M Trivedi;S Gray;D Patrick;D Delaney;K Watabayashi;P Litwin;P Shah;K Crew;M Yee;M Redman;J Unger;V Papadimitrakopoulou;J Johnson;K Kelly;D Gandara;RS Herbst;D Hershman;S Ramsey
Journal / Conference
Journal of Oncology Practice Apr 2;OP2000770. doi: 10.1200/OP.20.00770. Online ahead of print
Year
2021
Research Committee(s)
Cancer Care Delivery and Lung
PMID
PMID33797955

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

Authors
S Pal;C Tangen;I Thompson;N Balzer-Haas;D George;D Heng;B Shuch;M Stein;M Tretiakova;P Humphrey;A Adeniran;V Narayan;G Bjarnason;U Vaishampayan;A Alva;T Zhang;S Cole;M Plets;J Wright;P Lara
Journal / Conference
Lancet Feb 20;397(10275):695-703. doi: 10.1016/S0140-6736(21)00152-5. Epub 2021 Feb 13.
Year
2021
Research Committee(s)
Genitourinary
PMID
PMID33592176
Study Number(s)
S1500